No Picture
Trading Ideas

Investors await data on coronavirus drugs as market rally builds

Clinical data on potential treatments for the new coronavirus could help sustain a market bounce that has buoyed stocks after last month’s plunge, as investors look for signs that authorities may be able to stabilize the pandemic. Highly anticipated data for a Gilead Sciences Inc experimental antiviral drug are expected later this month. Analysts are also awaiting results in the near-term for products already approved for other conditions from companies such as Roche Holding and Regeneron Pharmaceuticals. …read more […]

No Picture
Trading Ideas

Molson Coors (TAP) Dividend History and Safety

Molson Coors (NYSE: TAP) dividend yield has climbed with the recent market drop. Since the start of the year, it’s climbed from below 3% to over 5%. Now that we’ve likely entered a recession, many companies will see a decrease in sales. Although, alcohol stocks tend to do relatively well during a downturn.
Molson falls under the Consumer Staple Stocks category. If you’d like to, you can open that link to see 20 other stocks with reliable dividends. And today, we’re going to look at TAP dividend history. But first, let’s look at the company overview.
Molson Coors Business Overview
Molson Coors is …read more […]

No Picture
Trading Ideas

Can Luckin Coffee Stock Recover from Accounting Fraud?

Luckin Coffee (Nasdaq: LK) may not be as well known in America as Starbucks (Nasdaq: SBUX). But in China, the “Little Blue Cup” as it is affectionately known there, is huge. Or should I say, it’s venti? But even in America, investors in Luckin Coffee stock know the brand well.
In fact, Luckin Coffee now has more coffee stores in China than Starbucks does by several hundred. And until this week, it may have seemed poised to dominate Starbucks as China’s coffee of choice for the foreseeable future.
But after some nasty headlines about accounting fraud at the company this past week, …read more […]